Knopp Biosciences
Pittsburgh
About Knopp Biosciences
Knopp Biosciences is a drug discovery and development company that focuses on delivering breakthrough treatments in neurological disorders through innovation, experience, and partnership. The company targets diseases imposing high costs on the healthcare system, with patient populations clearly identifiable using validated biomarkers or genetic testing. The company's goal is to accelerate and advance treatment, change the course of diseases, and improve the lives of the patients and their families. Knopp Biosciences was founded in 2004 and is headquartered in Pittsburgh, Pennsylvania.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $164.0M
- Funding stage: Late Stage Venture
- Last round: Series C (Nov 2020)
- Website: knoppbio.com
- Phone: +1 412-488-1776
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/knopp-biosciences-132079 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.